Antepartum glucocorticoid therapy combined with phenobarbitone and ritodrine for prevention of respiratory distress syndrome (RDS) in pre-term infants.
D001623:Betamethasone / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D010634:Phenobarbital / Q000627:therapeutic use*; D011247:Pregnancy; D011412:Propanolamines / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control*; D012312:Ritodrine / Q000627:therapeutic use*
D011412:Propanolamines; D001623:Betamethasone; D012312:Ritodrine; D010634:Phenobarbital